Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,134 public trials 1,863 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

NCT07462377

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • Sarah Cannon and HCA Research Institute Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Site 105 - START Los Angeles Los Angeles, California, United States
  • Site 104 - START New Jersey East Brunswick, New Jersey, United States
View Trial Details
Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NCT06293898

Conditions
Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +51 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Los Angeles, California, United States
  • Scripps Health San Diego, California, United States
View all 26 locations
View Trial Details
Recruiting

Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain Metastasis

NCT06315010

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +16 more
Locations
  • Medical University of Vienna Vienna, Austria
  • Ludwig-Maximilians-University Munich München, Germany
  • Medizinische Universität Graz Graz, Austria
  • Hospital de Vinalopó Elche, Alicante, Spain
View all 17 locations
View Trial Details
Recruiting

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

NCT06750185

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +28 more
Locations
  • Norton Cancer Institute PARENT Louisville, Kentucky, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Carolina BioOncology Institute, LLC Huntersville, North Carolina, United States
  • Rhode Island Hospital East Providence, Rhode Island, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

NCT07541170

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Community Cancer Institute (CCI) Clovis, California, United States
  • Piedmont Cancer Institute, PC Atlanta, Georgia, United States
  • Profound Research, LLC Farmington Hills, Michigan, United States
  • Cancer Care Specialists Reno, Nevada, United States
View all 19 locations
View Trial Details
Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

NCT07006727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • University Of Iowa Iowa City, Iowa, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Corewell Health William Beaum Hosp Royal Oak, Michigan, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

NCT06253871

Conditions
Brain Diseases, Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, +36 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Miami Miami, Florida, United States
View all 53 locations
View Trial Details
Recruiting

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

NCT07166601

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • NEXT Oncology San Antonio, Texas, United States
  • Princess Margaret Cancer Centre Toronto, Canada
  • National Cancer Center Hospital Chūōku, Japan
View Trial Details

Related conditions